[A new criterion for hCG administration in human IVF programs: importance of serum LH levels]

M Jinno1, K Sugimura, T Kobayashi

  • 1Department of Obstetrics and Gynecology, School of Medicine, Keio University, Tokyo.

Insights

A new method for timing human chorionic gonadotropin (hCG) to trigger ovulation for in vitro fertilization (IVF) uses serum luteinizing hormone (LH) levels. This approach optimizes pregnancy success rates in IVF cycles.

Area of Science:

  • Reproductive Endocrinology
  • In Vitro Fertilization (IVF)

Context:

  • Optimizing ovulation induction is crucial for IVF success.
  • Current protocols often rely on follicle size and estradiol levels, which can be variable.
  • A more precise method for timing human chorionic gonadotropin (hCG) administration is needed.

Purpose:

  • To introduce and evaluate a novel, simple criterion for timing hCG administration in IVF based on serum luteinizing hormone (LH) levels.
  • To determine the efficacy of this LH-based criterion in achieving pregnancy.

Summary:

  • A new criterion for hCG administration in IVF was developed, utilizing daily serum LH measurements.
  • hCG was administered the night of the first day the LH level exceeded a calculated 'J level', irrespective of follicle size or estradiol.
  • This method resulted in total and ongoing pregnancy rates of 35% and 27% per cycle, respectively.
  • Deviations of one day in hCG administration decreased pregnancy rates.
  • Successful pregnancies occurred across a broad range of dominant follicle diameters (14-21 mm) and estradiol levels (229-2,050 pg/ml).

Impact:

  • Serum LH level monitoring provides a reliable parameter for timing hCG administration in IVF.
  • This criterion may improve pregnancy outcomes by optimizing the timing of ovulation induction.
  • The simplicity of the criterion allows for straightforward clinical application.